The 30 faculty, staff, and students who signed up for the “three-day field experience” taking place this weekend at the School of Nursing and Health Studies don’t know what they are getting into, but they have been forewarned to prepare for disaster.
A surgeon at the University of Miami Miller School of Medicine has pioneered a new, minimally invasive surgical technique for treating pars fractures, a painful and debilitating back injury that can stop adolescent athletes in their tracks.
A research team at the University of Miami Miller School of Medicine has found a potential new strategy for treating diabetic kidney disease. “We have identified a new lipid that is deficient in diabetic kidney disease,” said Alessia Fornoni, M.D., Ph.D., professor of medicine, chief of the Katz Family Division of Nephrology and Hypertension, and director of the Peggy and Harold Katz Family Drug Discovery Center.
The Faculty Council of the University of Miami Miller School of Medicine held its second annual awards program during its transitional meeting of the academic year on May 28. Two awards — one for research and one for teaching — were presented to honor the contributions of beginning and mid-career faculty members to the Miller School and its mission.
Holtz Children’s Hospital at the University of Miami/Jackson Memorial Medical Center is among the nation’s best children’s hospitals, according to the U.S. News & World Report Best Children’s Hospitals rankings. Published online today, the rankings feature the top 50 hospitals in each of 10 pediatric specialties.
Mary Lanham, a senior professional with more than 20 years’ experience in strategic marketing and communications management in academic medicine, will join UHealth and the Miller School of Medicine as chief marketing and communications officer on June 24. Lanham comes to the University of Miami from the University of Maryland Medical System, where she was senior vice president and chief marketing and communications officer.
Recent advances in regenerative medicine and the promise of future therapeutics based on stem cell research came together in a series of presentations at the 2019 ISCI Symposium. A welcome and introduction by University of Miami Miller School of Medicine Dean Henri R. Ford, M.D., M.H.A., kicked off the event, which the Interdisciplinary Stem Cell Institute (ISCI) hosted at the Lois Pope LIFE Center.
UHealth CEO Edward Abraham, M.D., and Miller School Dean Henri R. Ford, M.D., M.H.A., joined forces Wednesday evening to express their gratitude for the impressive accomplishments of the past year and to chart an ambitious path forward in their first “State of UHealth and the Miller School of Medicine” address.
Jodie Barkin, M.D. ’11, admires his father’s commitment to patients with pancreatic diseases and other gastrointestinal disorders. “My dad is a godfather in the field of pancreatology,” he says. “It’s very special for me to work with him as a partner, mentor, and colleague. He’s a great role model for having an accomplished career in academic medicine.”
Guillermo “Willy” Prado, Ph.D., dean of the University of Miami Graduate School and professor of public health at the University of Miami Miller School of Medicine, was named president of the Society for Prevention Research (SPR).